BCHE and early-onset autosomal dominant Alzheimer disease: Despite the lack of research in this field, in some cases, the incorporation of the rhodanine core with other functional groups has led to compounds with strong cholinesterase inhibitory properties, thus indicating possible therapeutic effects against the Alzheimer disease (VI and VII) (Fig. 1).30–32